This issue of Dermatologic Clinics, guest edited by John E. Harris, MD, PhD, is devoted to Vitiligo. Articles in this timely issue include: History of Vitiligo Management; Quality of Life/Burden of Disease; Comorbidities/Systemic Effects; Skin Cancer Risk (NMSC/Melanoma); Presentations, Signs of Activity, Differential Diagnosis; Segmental Vitiligo; Chemical-Induced Vitiligo; Medical Therapy and Maintenance of Vitiligo; Phototherapy and Combination Therapies for Vitiligo; Surgical Therapy; Depigmentation Therapy; Special Considerations in Children with Vitiligo; Role of Diet and Supplements in Vitiligo Management; Genetics; Pathogenesis and Emerging Treatments; and Repigmentation/Melanocyte Regeneration in Vitiligo.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Preface - p. xi 8. The Medical Treatment of Vitiligo: An Historical Review - p. 107 9. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients - p. 117 10. Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients - p. 129 11. Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo - p. 135 12. Segmental Vitiligo - p. 145 13. Chemical-Induced Vitiligo - p. 151 14. Medical and Maintenance Treatments for Vitiligo - p. 163 15. Phototherapy and Combination Therapies for Vitiligo - p. 171 16. Surgical Therapies for Vitiligo - p. 193 17. Repigmentation through Melanocyte Regeneration in Vitiligo - p. 205 18. Depigmentation Therapies for Vitiligo - p. 219 19. Special Considerations in Children with Vitiligo - p. 229 20. The Role of Diet and Supplements in Vitiligo Management - p. 235 21. Genetics of Vitiligo - p. 245 22. Vitiligo Pathogenesis and Emerging Treatments - p. 257 23. Index - p. 267
No hay muestra disponible
No hay ficha técnica disponible
This issue of Dermatologic Clinics, guest edited by John E. Harris, MD, PhD, is devoted to Vitiligo. Articles in this timely issue include: History of Vitiligo Management; Quality of Life/Burden of Disease; Comorbidities/Systemic Effects; Skin Cancer Risk (NMSC/Melanoma); Presentations, Signs of Activity, Differential Diagnosis; Segmental Vitiligo; Chemical-Induced Vitiligo; Medical Therapy and Maintenance of Vitiligo; Phototherapy and Combination Therapies for Vitiligo; Surgical Therapy; Depigmentation Therapy; Special Considerations in Children with Vitiligo; Role of Diet and Supplements in Vitiligo Management; Genetics; Pathogenesis and Emerging Treatments; and Repigmentation/Melanocyte Regeneration in Vitiligo.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Preface - p. xi 8. The Medical Treatment of Vitiligo: An Historical Review - p. 107 9. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients - p. 117 10. Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients - p. 129 11. Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo - p. 135 12. Segmental Vitiligo - p. 145 13. Chemical-Induced Vitiligo - p. 151 14. Medical and Maintenance Treatments for Vitiligo - p. 163 15. Phototherapy and Combination Therapies for Vitiligo - p. 171 16. Surgical Therapies for Vitiligo - p. 193 17. Repigmentation through Melanocyte Regeneration in Vitiligo - p. 205 18. Depigmentation Therapies for Vitiligo - p. 219 19. Special Considerations in Children with Vitiligo - p. 229 20. The Role of Diet and Supplements in Vitiligo Management - p. 235 21. Genetics of Vitiligo - p. 245 22. Vitiligo Pathogenesis and Emerging Treatments - p. 257 23. Index - p. 267
No hay muestra disponible
No hay ficha técnica disponible
